Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs.
Giordano Attianese GMP, Shui S., Cribioli E., Triboulet M., Scheller L., Hafezi M., Reichenbach P., Gainza P., Georgeon S., Correia B.E. et al., 2024/10/29. Proceedings of the National Academy of Sciences of the United States of America, 121 (44) pp. e2405085121. Peer-reviewed.
A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor.
Reichenbach P., Giordano Attianese GMP, Ouchen K., Cribioli E., Triboulet M., Ash S., Saillard M., Vuillefroy de Silly R., Coukos G., Irving M., 2023/09. Nature biomedical engineering, 7 (9) pp. 1063-1080. Peer-reviewed.
